Correlation Between Magle Chemoswed and Corline Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Magle Chemoswed and Corline Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Magle Chemoswed and Corline Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Magle Chemoswed Holding and Corline Biomedical AB, you can compare the effects of market volatilities on Magle Chemoswed and Corline Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Magle Chemoswed with a short position of Corline Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Magle Chemoswed and Corline Biomedical.

Diversification Opportunities for Magle Chemoswed and Corline Biomedical

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Magle and Corline is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Magle Chemoswed Holding and Corline Biomedical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corline Biomedical and Magle Chemoswed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Magle Chemoswed Holding are associated (or correlated) with Corline Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corline Biomedical has no effect on the direction of Magle Chemoswed i.e., Magle Chemoswed and Corline Biomedical go up and down completely randomly.

Pair Corralation between Magle Chemoswed and Corline Biomedical

Assuming the 90 days trading horizon Magle Chemoswed Holding is expected to under-perform the Corline Biomedical. But the stock apears to be less risky and, when comparing its historical volatility, Magle Chemoswed Holding is 1.88 times less risky than Corline Biomedical. The stock trades about -0.11 of its potential returns per unit of risk. The Corline Biomedical AB is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  1,500  in Corline Biomedical AB on August 30, 2025 and sell it today you would earn a total of  310.00  from holding Corline Biomedical AB or generate 20.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Magle Chemoswed Holding  vs.  Corline Biomedical AB

 Performance 
       Timeline  
Magle Chemoswed Holding 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Magle Chemoswed Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Corline Biomedical 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Corline Biomedical AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Corline Biomedical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Magle Chemoswed and Corline Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Magle Chemoswed and Corline Biomedical

The main advantage of trading using opposite Magle Chemoswed and Corline Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Magle Chemoswed position performs unexpectedly, Corline Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corline Biomedical will offset losses from the drop in Corline Biomedical's long position.
The idea behind Magle Chemoswed Holding and Corline Biomedical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum